India Keratoconus Treatment Market Research Report By Keratoconus Type (Corneal Hydrops, Forme Fruste Keratoconus, Posterior Keratoconus, Keratoglobus, Pellucid Marginal Degeneration), By Treatment Type (Lenses, Surgery, Corneal Cross-Linking) andBy End User (Eye Clinics, Hospitals)- Forecast to 2035

India Keratoconus Treatment Market Overview

As per MRFR analysis, the India Keratoconus Treatment Market Size was estimated at 19.29 (USD Million) in 2023. The India Keratoconus Treatment Market Industry is expected to grow from 20(USD Million) in 2024 to 38.4 (USD Million) by 2035. The India Keratoconus Treatment Market CAGR (growth rate) is expected to be around 6.11% during the forecast period (2025 - 2035).

Key India Keratoconus Treatment Market Trends Highlighted

The India Keratoconus Treatment Market is witnessing significant trends driven by an increase in awareness about eye health among the Indian population. As more individuals understand the implications of keratoconus and the need for early diagnosis and intervention, there is a corresponding rise in demand for effective treatment options. The Indian government's initiatives on healthcare improvements, along with the proliferation of advanced diagnostic tools and treatment technologies, play a crucial role in shaping market dynamics. Opportunities to be explored in this market include the potential for introducing innovative treatment modalities such as corneal cross-linking and personalized contact lenses tailored specifically for keratoconus patients.An expanding interest exists in increasing treatment access in rural areas, where awareness and resources are limited. 

Efforts directed towards updating training for health workers involve treatment of the latest techniques that offer untapped prospects. Recently, there has been a trend towards increased popularity of less invasive surgical procedures because of the reduced recovery time. Online health services are also transforming patient participation through remote consultations and diagnostics which allows faster referrals and is transforming patients’ engagement to specialized treatment for keratoconus. This eye care is also being integrated into the healthcare system of India with active partnerships of healthcare institutions and manufacturers who are concerned with providing low cost solutions for keratoconus eyecare.Overall, the convergence of technological advancements, increased healthcare access, and focused patient education are steering the India Keratoconus Treatment Market toward a more accessible and advanced future.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

India Keratoconus Treatment Market Drivers

Increasing Prevalence of Keratoconus in India

The rising incidence of keratoconus among the Indian population is a significant driver for the India Keratoconus Treatment Market Industry. Reports indicate that the prevalence of keratoconus ranges from 1 in 2,000 to 1 in 10,000 individuals in the general population, but studies suggest that rates may be as high as 1 in 375 in certain regions, like North India. The increasing awareness and improved diagnosis of eye conditions are expected to foster market growth as more individuals seek treatment.The All India Ophthalmological Society has also emphasized the importance of screening and early intervention strategies for detecting keratoconus, which aligns with the growing number of eye care facilities and surgeries being performed, contributing to market expansion.

Advancements in Ophthalmic Technologies

Technological innovations in ophthalmic treatments and devices play a crucial role in the growth of the India Keratoconus Treatment Market Industry. With the advent of cross-linking procedures, corneal transplants, and advanced contact lens options, the treatment landscape has evolved significantly. In recent years, the Indian healthcare industry has seen substantial investments in Research and Development from organizations such as the Council of Scientific and Industrial Research, which work to enhance treatment methods.These advancements have led to high patient satisfaction rates, promoting more individuals to seek treatment and thereby boosting market growth.

Government Initiatives and Support for Eye Health

Indian government initiatives aimed at improving eye health and access to eye care services are critical to the growth of the India Keratoconus Treatment Market Industry. Programs like the National Programme for Control of Blindness and Visual Impairment have been instrumental in raising awareness about eye health and providing subsidized treatments and surgeries. Reports have indicated that approximately 25 million people in India suffer from eye disorders, and governmental focus on eye care services is fueled by these staggering numbers.Collaborations between the Ministry of Health and wellness organizations lead to increased funding for eye research, particularly for conditions such as keratoconus, improving treatment accessibility for the population.

India Keratoconus Treatment Market Segment Insights

Keratoconus Treatment Market Keratoconus Type Insights

The India Keratoconus Treatment Market exhibits a diverse range of conditions categorized under the Keratoconus Type segment, highlighting the complexity of this eye disorder. Among the various forms are Corneal Hydrops, Forme Fruste Keratoconus, Posterior Keratoconus, Keratoglobus, and Pellucid Marginal Degeneration, each presenting unique challenges for diagnosis and treatment. Corneal Hydrops is characterized by sudden swelling of the cornea, leading to significant visual impairment, and often necessitates immediate medical intervention, reflecting its critical nature in the overall treatment landscape. Forme Fruste Keratoconus, a more subtle manifestation, often remains undetected until vision deteriorates significantly; therefore, early detection is essential for effective management and demonstrates the need for advanced diagnostic tools in the market. 

Meanwhile, Posterior Keratoconus, which affects the back surface of the cornea, is less common but can lead to progressive vision loss, emphasizing the importance of tailored treatment approaches based on individual patient profiles.Keratoglobus, an abnormal corneal shape resulting in thinning of the cornea, poses its own set of challenges, with patients often requiring specialized contacts or surgical interventions to manage vision effectively. In the scope of the India Keratoconus Treatment Market, Pellucid Marginal Degeneration stands out as well, where the cornea doesn’t approach typical keratoconus in severity yet still leads to significant refractive errors and visual disturbances. This diversity within the Keratoconus Type segment illustrates the multifaceted nature of keratoconus-related disorders, driving the advancement and diversification of treatment methods. 

Additionally, with an evolving demographic of patients and increasing awareness regarding corneal health, there is a growing need for innovative solutions tailored to each type, further substantiating the importance of research and development within the India Keratoconus Treatment Market. The interplay between these conditions and how treatment options are formulated highlights significant growth opportunities in the sector, as stakeholders ranging from healthcare providers to medical equipment manufacturers seek to address the diverse needs of patients afflicted by keratoconus across the country.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

Keratoconus Treatment Market Treatment Type Insights

The India Keratoconus Treatment Market is increasingly segmented by Treatment Type, which plays a crucial role in addressing this eye condition. The Treatment Type primarily includes options such as Lenses, Surgery, and Corneal Cross-Linking. Lenses, especially custom hard contact lenses, are widely regarded for their effectiveness in improving vision in Keratoconus patients, making them a preferred choice among many individuals. Glaucoma Surgery, including procedures like corneal transplants, offers long-term solutions for severe cases, reflecting its significant position within the market.Corneal Cross-Linking, an innovative treatment that strengthens corneal tissue, is gaining traction due to its ability to halt disease progression and improve visual outcomes. The increasing awareness of Keratoconus, along with advances in technology and treatment methods, enhances the overall landscape of the India Keratoconus Treatment Market, providing ample opportunities for growth and development. As these treatments evolve, they become more accessible, catering to the rising demand for effective solutions, thus reinforcing their importance in the market.

Keratoconus Treatment Market End User Insights

The India Keratoconus Treatment Market has seen impressive growth, with Eye Clinics and Hospitals playing critical roles as key end users within the market. Eye Clinics are increasingly becoming preferred destinations for keratoconus treatment due to their specialized services, advanced technologies, and the personalized care provided by ophthalmologists. These clinics cater to the rising number of patients seeking early diagnosis and treatment, which significantly contributes to patient satisfaction and improved outcomes. Hospitals also hold a significant position, incorporating comprehensive treatment modalities and specialized units for eye care.

They often offer more complex surgical procedures and have extensive resources in terms of Research and Development capabilities which help in addressing severe cases of keratoconus. The growing awareness about eye health and the availability of advanced keratoconus treatment options are driving factors behind the expansion of both Eye Clinics and Hospitals in the market. Additionally, India, with its large population and increasing prevalence of keratoconus, presents a notable opportunity for stakeholders in the market. Overall, the interplay between these end users is leading to enhanced treatment options and improved accessibility for patients affected by keratoconus in India.

India Keratoconus Treatment Market Key Players and Competitive Insights

The competitive insights of the India Keratoconus Treatment Market reveal a dynamic landscape marked by innovation and the presence of several key players aiming to address the growing incidence of keratoconus in the region. With an increasing awareness of eye health and advanced treatment options, the market has become attractive for various healthcare providers and pharmaceutical companies. The treatment strategies are evolving, focusing on both non-invasive and surgical options, with a significant emphasis on enhancing patient outcomes and improving accessibility. Emerging technologies, such as crosslinking procedures and specialized contact lenses, are reshaping the market, pushing competitors to differentiate their offerings and capture a larger share in this niche yet critical segment. The competitive strategies encompass research and development, collaborations with healthcare professionals, and aggressive marketing campaigns aimed at educating the population about keratoconus and the available treatment solutions.

Friedrichs has established a notable presence in the India Keratoconus Treatment Market, leveraging its strengths in cutting-edge technologies and high-quality medical devices. The company is renowned for its dedication to research and development, ensuring that it stays at the forefront of innovative treatment methodologies tailored for keratoconus. Friedrichs has fostered strong partnerships with local ophthalmology clinics and hospitals, enhancing its visibility and accessibility within the region. The company's commitment to education and training also plays a pivotal role in its strategy, as it seeks to empower healthcare professionals with the latest knowledge and tools required for effective keratoconus management. 

This focus has fostered trust and recognition within the medical community, allowing Friedrichs to create a competitive edge in the market.Novartis has made significant strides in the India Keratoconus Treatment Market, bolstered by its robust portfolio of ophthalmic products and services. The company is known for its extensive research initiatives and has introduced specialized treatments that cater to the needs of keratoconus patients, enhancing visual acuity and overall eye health. Novartis' strengths are amplified by its strategic mergers and acquisitions, allowing for expanded access and market penetration in India. 

The focus on patient-centric solutions has enabled Novartis to establish a solid reputation among healthcare professionals and patients alike. Moreover, the company actively engages in educational programs and awareness campaigns pertaining to keratoconus, thereby ensuring better understanding and management of the condition among practitioners and patients. This comprehensive approach not only underlines Novartis' commitment to eye health in India but also solidifies its standing as a leader in the keratoconus treatment arena.

Key Companies in the India Keratoconus Treatment Market Include

• Friedrichs


• Novartis


• Crowley Eye Care


• Bausch Health


• Essilor


• CooperVision


• Avedro


• Visionary Optics


• Alcon


• EyeCare Partners


• AbbVie


• Gulf Coast Veterinary Specialists


• Johnson and Johnson


• Ziemer Ophthalmic Systems

India Keratoconus Treatment Market Industry Developments

In recent months, the India Keratoconus Treatment Market has seen notable advancements and developments. Friedrichs and Novartis have been actively involved in expanding their product portfolios to address the rising prevalence of keratoconus in India, with new treatment options being introduced. CooperVision has also launched innovative technologies in the area of scleral lenses, which are proving beneficial for patients. In terms of partnerships and collaborations, Crowley Eye Care is reportedly joining forces with local ophthalmology clinics to enhance patient access to specialized keratoconus treatments. 

Growth in market valuation has been influenced by increased awareness and screening for keratoconus, supported by government initiatives aimed at improving eye care accessibility across the country, particularly in urban and rural settings. In 2022, Alcon and Bausch Health made substantial investments in Research and Development initiatives specific to keratoconus treatment modalities, bringing forth newer methodologies. Moreover, there have been discussions regarding mergers in this segment, yet as of now, nothing has been finalized or publicly disclosed. The combination of technological advancements and strategic partnerships is expected to further contribute to the development of the keratoconus treatment landscape in India.

India Keratoconus Treatment Market Segmentation Insights

Keratoconus Treatment Market Keratoconus Type Outlook

• Corneal Hydrops


• Forme Fruste Keratoconus


• Posterior Keratoconus


• Keratoglobus


• Pellucid Marginal Degeneration

Keratoconus Treatment Market Treatment Type Outlook

• Lenses


• Surgery


• Corneal Cross-Linking

Keratoconus Treatment Market End User Outlook

• Eye Clinics


• Hospitals

Report Attribute/Metric Source:	Details
MARKET SIZE 2018	19.29(USD Million)
MARKET SIZE 2024	20.0(USD Million)
MARKET SIZE 2035	38.4(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR)	6.11% (2025 - 2035)
REPORT COVERAGE	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR	2024
MARKET FORECAST PERIOD	2025 - 2035
HISTORICAL DATA	2019 - 2024
MARKET FORECAST UNITS	USD Million
KEY COMPANIES PROFILED	Friedrichs, Novartis, Crowley Eye Care, Bausch Health, Essilor, CooperVision, Avedro, Visionary Optics, Alcon, EyeCare Partners, AbbVie, Gulf Coast Veterinary Specialists, Johnson and Johnson, Ziemer Ophthalmic Systems
SEGMENTS COVERED	Keratoconus Type, Treatment Type, End User
KEY MARKET OPPORTUNITIES	Innovative treatment technologies, Growing awareness and education, Rising prevalence of keratoconus, Increased healthcare funding, Expansion of telemedicine services
KEY MARKET DYNAMICS	Increasing prevalence of keratoconus, Advancements in treatment technologies, Rising awareness among patients, Growing number of eye care professionals, Availability of affordable treatment options
COUNTRIES COVERED	India